Skip to Main Content
National Association for Home Care & Hospice
Twitter Facebook Pintrest
A A A
Print
:: NAHC Report
 
  NAHC Report: Issue# 2724, 8/11/2015
Follow us on: 
ARTICLE ARCHIVES MEMBER RESOURCES eNEWSLETTERS CARING STORE
More Representatives Co-Sign Letter to CMS to Prevent Payment Cuts and Unsustainable Value Based Purchasing Penalty Percentage
CMS to Address Problems with Hospice Reporting of Anti-Cancer and Anti-Emetic Drugs on Claims
For Your Information: The Final FY2016 Hospice Rule: A Comprehensive Update on Payment and Policy Issues
Job Corner: DIRECTOR COMMUNITY NURSES INC.
Email Center

 

Manage Your Account Contact the Editor Ensure Delivery Advertise in NAHC Report

More Representatives Co-Sign Letter to CMS to Prevent Payment Cuts and Unsustainable Value Based Purchasing Penalty Percentage

Momentum continues to build in the ongoing effort to encourage members of the U.S. House of Representatives to sign the letter to the Centers for Medicare & Medicaid Services (CMS) to prevent the proposed home health case mix cut and the proposed Home Health Value Based Purchasing (HHVBP) penalty percentage.  The letter is being circulated to House members by Representatives Greg Walden (R-OR-2), Tom Price (R-GA-6), James P. McGovern (D-MA-2), and Earl Blumenauer (D-OR-3) (see previous NAHC Report article here). Most recently, four additional members have agreed to co-sign the letter, bringing the current total number of co-signers to eight. The four addition members are Representatives Yvette D. Clarke (D-NY-9), Charles W. Boustany Jr., M.D. (R-LA-3), Alcee L. Hastings (D-FL-20), and Ralph Abraham, M.D. (R-LA-5).

The National Association for Home Care & Hospice (NAHC) is encouraging members of the U.S. House of Representatives to sign the letter. Please use NAHC’s Legislation Action Center (available here) to encourage your Representative to sign the letter today. The deadline for Representatives to sign the letter is September 2.

:: Read Full Article

CMS to Address Problems with Hospice Reporting of Anti-Cancer and Anti-Emetic Drugs on Claims

Since imposition of the requirement to report prescription drugs on hospice claims in April 2014, some hospices have had claims reporting anti-cancer and anti-emetic drugs returned to provider (RTP). The Centers for Medicare & Medicaid Services (CMS) and the Medicare Administrative Contractors (MACs) have discovered that this is occurring because the Common Working File (CWF) contains an edit that restricts the allowable types of bills on which certain anti-cancer and anti-emetic drugs may be submitted; hospice bills, under current processing rules, may not include these prescription medications. Until this edit can be corrected, CMS is directing the MACs to instruct hospices to remove or omit service lines for oral anti-cancer and anti-emetic drugs from claims so that they may process normally. This action should continue until January 1, 2016, when the edit correction should become effective. After the edit correction is in place, hospices will be encouraged to submit claim adjustments for all claims that are within the timely filing period to restore the reporting of the oral anti-cancer and anti-emetic drugs so that CMS has accurate data on usage of these medications.

:: Read Full Article

The Final FY2016 Hospice Rule: A Comprehensive Update on Payment and Policy Issues
Tuesday, August 18, 2015, 1:00 PM – 2:00 PM Eastern

Program Description:

This program will explore hospice policy changes CMS finalized in recent weeks, and provide a comprehensive update of CMS' plans and timelines for implementing reform of the hospice payment system, and changes related to the inpatient and aggregate Caps, the Hospice Quality Reporting Program (HQRP), and diagnosis coding on claims. Presenters will also discuss potential future policy changes in the hospice arena.

Program Objectives:

  • Describe key elements of CMS' planned revisions to the payment system for Routine Home Care (RHC)
  • Outline changes affecting hospice payment CAP monitoring and reporting
  • Discuss various aspects of the Hospice Quality Reporting Program and anticipated future activities
  • Explain CMS' clarification regarding diagnosis coding on hospice claims

Panel of NAHC Experts:

  • Val J. Halamandaris, President, NAHC
  • Theresa M. Forster, Vice President for Hospice Policy & Programs, NAHC
  • Katie Wehri, Hospice Policy Expert, NAHC

Registration:

Webcast and/or Recording
Member:  FREE      Non-member:  $150.00

Click Here to Register!

DIRECTOR COMMUNITY NURSES INC.

Community Nurses, Inc. was named by Becker’s Hospital Review as one of the top 150 Great Places to Work in Healthcare in the United States for 2015 – Come join our team!

POSITION SUMMARY

The Director executes direct administration of the Community Nurses Inc. System Home Health and Hospice departments, Adult Day Services and Support Services as evidenced by achieving results in clinical quality, service excellence, human resources management and financial management.  The Director assists in developing and implementing a strategic plan for the growth and development of Community Nurses Inc. services in collaboration with the AVP of Home Health/Hospice and other Penn Highlands Healthcare leadership.

JOB QUALIFICATIONS

  • Bachelors Degree in Nursing, Business Administration, or related field required; Masters Degree in Nursing, Business Administration, or related field preferred.
  • System management experience preferred.
  • Five years home health/hospice nursing experience preferred.
  • Two years management experience in home health/hospice setting required.
  • Demonstrates effective communication and collaboration skills with physician and all other members of the health care team
  • Progressive and successful work history
  • Specialty certification preferred

Interested candidates please submit a resume and cover letter for consideration. FAX:  814-788-8046 OR E-MAIL: careers@elkregional.org

 

©  National Association for Home Care & Hospice. All Rights Reserved.